MARKET

MRK

MRK

Merck & Co
NYSE
144.30
+0.49
+0.34%
After Hours: 144.19 -0.11 -0.08% 19:47 10/02 EDT
OPEN
143.77
PREV CLOSE
143.81
HIGH
144.35
LOW
142.73
VOLUME
9.66M
TURNOVER
--
52 WEEK HIGH
156.00
52 WEEK LOW
75.80
MARKET CAP
356.01B
P/E (TTM)
115.25
1D
5D
1M
3M
1Y
5Y
1D
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot
Seeking Alpha · 3h ago
Moderna, Illumina lead healthcare gains in September as medtech drags
Seeking Alpha · 6h ago
Dividend Champion, Contender, And Challenger Highlights: Week October 4
Seeking Alpha · 23h ago
Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data
NASDAQ · 1d ago
8 Of 11 Sectors Rise Friday As Growth Leads
Benzinga · 1d ago
Shattuck Labs price target raised to $14 from $11 at Wedbush
TipRanks · 1d ago
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
Seeking Alpha · 1d ago
Merck (MRK) Advances Tulisokibart After Positive Phase 2b Hidradenitis Suppurativa Data
Simply Wall St · 1d ago
More
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Webull offers Merck & Co Inc stock information, including NYSE: MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.